Bausch + Lomb announced Clinical Ophthalmology has published results from an investigator-initiated study which evaluated the effectiveness of XIIDRA (lifitegrast ophthalmic solution) 5% in...
Alcon has announced the U.S. commercial availability of TRYPTYR® (acoltremon ophthalmic solution) 0.003%, the latest innovation for the treatment of the signs and symptoms...